ID   UBP32_HUMAN             Reviewed;        1604 AA.
AC   Q8NFA0; Q7Z5T3; Q9BX85; Q9Y591;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 32;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 32;
DE   AltName: Full=Renal carcinoma antigen NY-REN-60;
DE   AltName: Full=Ubiquitin thioesterase 32;
DE   AltName: Full=Ubiquitin-specific-processing protease 32;
DE   Flags: Precursor;
GN   Name=USP32; Synonyms=USP10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=12604796; DOI=10.1073/pnas.0437015100;
RA   Paulding C.A., Ruvolo M., Haber D.A.;
RT   "The Tre2 (USP6) oncogene is a hominoid-specific gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:2507-2511(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 331-1604 (ISOFORM 1).
RC   TISSUE=Testis;
RA   Sha J.H.;
RT   "Identification of a novel ubiquitin specific protease gene related to
RT   testes development from human testes cDNA library.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 536-1363 (ISOFORM 1), AND IDENTIFICATION
RP   AS A RENAL CANCER ANTIGEN.
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   ISOPRENYLATION AT CYS-1601.
RX   PubMed=17411337; DOI=10.1371/journal.pcbi.0030066;
RA   Maurer-Stroh S., Koranda M., Benetka W., Schneider G., Sirota F.L.,
RA   Eisenhaber F.;
RT   "Towards complete sets of farnesylated and geranylgeranylated
RT   proteins.";
RL   PLoS Comput. Biol. 3:634-648(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1173, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1372, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=20549504; DOI=10.1007/s00335-010-9268-4;
RA   Akhavantabasi S., Akman H.B., Sapmaz A., Keller J., Petty E.M.,
RA   Erson A.E.;
RT   "USP32 is an active, membrane-bound ubiquitin protease overexpressed
RT   in breast cancers.";
RL   Mamm. Genome 21:388-397(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1372, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1350; SER-1372; SER-1376
RP   AND SER-1588, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1454, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:20549504}.
CC   -!- INTERACTION:
CC       Q8IUH5:ZDHHC17; NbExp=2; IntAct=EBI-2511075, EBI-524753;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}. Golgi apparatus {ECO:0000269|PubMed:20549504}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NFA0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NFA0-2; Sequence=VSP_056307, VSP_056308;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF533230; AAM97922.1; -; mRNA.
DR   EMBL; AF350251; AAK30207.1; -; mRNA.
DR   EMBL; AC003962; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC037475; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC054344; AAH54344.1; -; mRNA.
DR   EMBL; AF155116; AAD42882.1; -; mRNA.
DR   CCDS; CCDS32697.1; -. [Q8NFA0-1]
DR   RefSeq; NP_115971.2; NM_032582.3. [Q8NFA0-1]
DR   UniGene; Hs.132868; -.
DR   ProteinModelPortal; Q8NFA0; -.
DR   SMR; Q8NFA0; -.
DR   BioGrid; 124189; 40.
DR   IntAct; Q8NFA0; 28.
DR   MINT; MINT-6779170; -.
DR   STRING; 9606.ENSP00000300896; -.
DR   iPTMnet; Q8NFA0; -.
DR   PhosphoSitePlus; Q8NFA0; -.
DR   SwissPalm; Q8NFA0; -.
DR   BioMuta; USP32; -.
DR   DMDM; 47606649; -.
DR   EPD; Q8NFA0; -.
DR   MaxQB; Q8NFA0; -.
DR   PaxDb; Q8NFA0; -.
DR   PeptideAtlas; Q8NFA0; -.
DR   PRIDE; Q8NFA0; -.
DR   DNASU; 84669; -.
DR   Ensembl; ENST00000300896; ENSP00000300896; ENSG00000170832. [Q8NFA0-1]
DR   Ensembl; ENST00000393003; ENSP00000376727; ENSG00000170832. [Q8NFA0-2]
DR   GeneID; 84669; -.
DR   KEGG; hsa:84669; -.
DR   UCSC; uc002iyo.2; human. [Q8NFA0-1]
DR   CTD; 84669; -.
DR   DisGeNET; 84669; -.
DR   GeneCards; USP32; -.
DR   HGNC; HGNC:19143; USP32.
DR   HPA; HPA044365; -.
DR   MIM; 607740; gene.
DR   neXtProt; NX_Q8NFA0; -.
DR   OpenTargets; ENSG00000170832; -.
DR   PharmGKB; PA134982542; -.
DR   eggNOG; KOG0044; Eukaryota.
DR   eggNOG; KOG1870; Eukaryota.
DR   eggNOG; COG5560; LUCA.
DR   GeneTree; ENSGT00670000097750; -.
DR   HOGENOM; HOG000202412; -.
DR   HOVERGEN; HBG057958; -.
DR   InParanoid; Q8NFA0; -.
DR   KO; K11837; -.
DR   OMA; EYVKYDA; -.
DR   OrthoDB; EOG091G01VD; -.
DR   PhylomeDB; Q8NFA0; -.
DR   TreeFam; TF324190; -.
DR   ChiTaRS; USP32; human.
DR   GenomeRNAi; 84669; -.
DR   PRO; PR:Q8NFA0; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000170832; -.
DR   CleanEx; HS_USP10; -.
DR   CleanEx; HS_USP32; -.
DR   ExpressionAtlas; Q8NFA0; baseline and differential.
DR   Genevisible; Q8NFA0; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IEA:InterPro.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 3.30.2230.10; -; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR006615; Pept_C19_DUSP.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR028135; Ub_USP-typ.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF06337; DUSP; 1.
DR   Pfam; PF13202; EF-hand_5; 2.
DR   Pfam; PF14836; Ubiquitin_3; 1.
DR   Pfam; PF00443; UCH; 1.
DR   SMART; SM00695; DUSP; 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF143791; SSF143791; 2.
DR   SUPFAM; SSF47473; SSF47473; 2.
DR   PROSITE; PS51283; DUSP; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Golgi apparatus;
KW   Hydrolase; Lipoprotein; Membrane; Metal-binding; Methylation;
KW   Phosphoprotein; Polymorphism; Prenylation; Protease;
KW   Reference proteome; Repeat; Thiol protease; Ubl conjugation pathway.
FT   CHAIN         1   1601       Ubiquitin carboxyl-terminal hydrolase 32.
FT                                /FTId=PRO_0000080663.
FT   PROPEP     1602   1604       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000396658.
FT   DOMAIN       91    126       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      228    263       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      264    299       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      369    585       DUSP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00613}.
FT   DOMAIN      734   1567       USP.
FT   CA_BIND     241    252       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     277    288       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   ACT_SITE    743    743       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   ACT_SITE   1526   1526       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES    1173   1173       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1350   1350       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1372   1372       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1376   1376       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1454   1454       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1588   1588       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1601   1601       Cysteine methyl ester. {ECO:0000255}.
FT   LIPID      1601   1601       S-farnesyl cysteine. {ECO:0000255}.
FT   VAR_SEQ     380    390       GWLERESRYGL -> TLETDQIYTRN (in isoform
FT                                2). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056307.
FT   VAR_SEQ     391   1604       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056308.
FT   VARIANT      76     76       H -> Y (in dbSNP:rs7208980).
FT                                /FTId=VAR_051536.
FT   VARIANT    1469   1469       A -> G (in dbSNP:rs3207630).
FT                                /FTId=VAR_051537.
FT   VARIANT    1568   1568       G -> R (in dbSNP:rs16944142).
FT                                /FTId=VAR_051538.
FT   VARIANT    1578   1578       T -> I (in dbSNP:rs16944136).
FT                                /FTId=VAR_051539.
FT   CONFLICT    884    884       H -> R (in Ref. 2; AAK30207).
FT                                {ECO:0000305}.
FT   CONFLICT   1167   1167       C -> S (in Ref. 2; AAK30207).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1604 AA;  181656 MW;  A621F764B76321E3 CRC64;
     MGAKESRIGF LSYEEALRRV TDVELKRLKD AFKRTCGLSY YMGQHCFIRE VLGDGVPPKV
     AEVIYCSFGG TSKGLHFNNL IVGLVLLTRG KDEEKAKYIF SLFSSESGNY VIREEMERML
     HVVDGKVPDT LRKCFSEGEK VNYEKFRNWL FLNKDAFTFS RWLLSGGVYV TLTDDSDTPT
     FYQTLAGVTH LEESDIIDLE KRYWLLKAQS RTGRFDLETF GPLVSPPIRP SLSEGLFNAF
     DENRDNHIDF KEISCGLSAC CRGPLAERQK FCFKVFDVDR DGVLSRVELR DMVVALLEVW
     KDNRTDDIPE LHMDLSDIVE GILNAHDTTK MGHLTLEDYQ IWSVKNVLAN EFLNLLFQVC
     HIVLGLRPAT PEEEGQIIRG WLERESRYGL QAGHNWFIIS MQWWQQWKEY VKYDANPVVI
     EPSSVLNGGK YSFGTAAHPM EQVEDRIGSS LSYVNTTEEK FSDNISTASE ASETAGSGFL
     YSATPGADVC FARQHNTSDN NNQCLLGANG NILLHLNPQK PGAIDNQPLV TQEPVKATSL
     TLEGGRLKRT PQLIHGRDYE MVPEPVWRAL YHWYGANLAL PRPVIKNSKT DIPELELFPR
     YLLFLRQQPA TRTQQSNIWV NMGNVPSPNA PLKRVLAYTG CFSRMQTIKE IHEYLSQRLR
     IKEEDMRLWL YNSENYLTLL DDEDHKLEYL KIQDEQHLVI EVRNKDMSWP EEMSFIANSS
     KIDRHKVPTE KGATGLSNLG NTCFMNSSIQ CVSNTQPLTQ YFISGRHLYE LNRTNPIGMK
     GHMAKCYGDL VQELWSGTQK NVAPLKLRWT IAKYAPRFNG FQQQDSQELL AFLLDGLHED
     LNRVHEKPYV ELKDSDGRPD WEVAAEAWDN HLRRNRSIVV DLFHGQLRSQ VKCKTCGHIS
     VRFDPFNFLS LPLPMDSYMH LEITVIKLDG TTPVRYGLRL NMDEKYTGLK KQLSDLCGLN
     SEQILLAEVH GSNIKNFPQD NQKVRLSVSG FLCAFEIPVP VSPISASSPT QTDFSSSPST
     NEMFTLTTNG DLPRPIFIPN GMPNTVVPCG TEKNFTNGMV NGHMPSLPDS PFTGYIIAVH
     RKMMRTELYF LSSQKNRPSL FGMPLIVPCT VHTRKKDLYD AVWIQVSRLA SPLPPQEASN
     HAQDCDDSMG YQYPFTLRVV QKDGNSCAWC PWYRFCRGCK IDCGEDRAFI GNAYIAVDWD
     PTALHLRYQT SQERVVDEHE SVEQSRRAQA EPINLDSCLR AFTSEEELGE NEMYYCSKCK
     THCLATKKLD LWRLPPILII HLKRFQFVNG RWIKSQKIVK FPRESFDPSA FLVPRDPALC
     QHKPLTPQGD ELSEPRILAR EVKKVDAQSS AGEEDVLLSK SPSSLSANII SSPKGSPSSS
     RKSGTSCPSS KNSSPNSSPR TLGRSKGRLR LPQIGSKNKL SSSKENLDAS KENGAGQICE
     LADALSRGHV LGGSQPELVT PQDHEVALAN GFLYEHEACG NGYSNGQLGN HSEEDSTDDQ
     REDTRIKPIY NLYAISCHSG ILGGGHYVTY AKNPNCKWYC YNDSSCKELH PDEIDTDSAY
     ILFYEQQGID YAQFLPKTDG KKMADTSSMD EDFESDYKKY CVLQ
//
